Response to PARP Inhibition in BARD1-Mutated Refractory Neuroblastoma,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Response to PARP Inhibition in BARD1-Mutated Refractory Neuroblastoma
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-08-15 , DOI: 10.1056/nejmc2403316
Margaret Cupit-Link ₁ , Kohei Hagiwara ₁ , Matthew Nagy ₂ , Selene C Koo ₁ , Brent A Orr ₁ , Eytan Ruppin ₂ , John Easton ₃ , Jinghui Zhang ₃ , Sara M Federico ₃

Affiliation

Some neuroblastomas carry disabling mutations in BARD1, a homologous recombination repair gene. A child with refractory neuroblastoma and a BARD1 mutation had a sustained response after treatment w...

中文翻译：